Working Group Meeting on Pertussis – March 6, 2013, Bethesda, Md.
The Infectious Diseases Society of America (IDSA), the National Foundation for Infectious Diseases, the Pediatric Infectious Diseases Society of America, and the National Vaccine Program Office (NVPO) are sponsoring a working group meeting on Wednesday, March 6, from 7:30 a.m. to 5:30 p.m. EST in Bethesda, Md., to discuss the resurgence of pertussis and to consider next steps.
Weather Update: The meeting will proceed as planned, but will now be held at the Hyatt Regency Bethesda, located at One Bethesda Metro Center (7400 Wisconsin Ave), Bethesda, Maryland, 20814. The webinar will also proceed as planned.
The agenda (PDF) includes epidemiology, pathogenesis, human immune response to disease and vaccination, mouse model of pertussis, non-human primate model and human challenge experiments, current status of vaccine development, regulatory considerations, and interim and long-term solutions.
A limited number of listen-only webinar slots are available (registration is required). Reserve your webinar seat now. Due to space restrictions, IDSA encourages colleagues at large agencies and organizations to share a slot. Reporters with questions should contact Ashley Mattys of PCI at firstname.lastname@example.org, 312-558-1770 or Diana Olson of IDSA at email@example.com, 703-299-0201.
According to the U.S. Centers for Disease Control and Prevention (CDC), the U.S. is experiencing the highest number of cases of pertussis since the 1950s. During 2012, more than 41,000 cases were provisionally reported across the country, including 18 deaths. Scientists and public health experts don’t fully understand why the resurgence is occurring. The purpose of the meeting is to inform future research projects and to consider new immunization strategies. Immunization remains the most effective strategy for preventing pertussis, and experts continue to recommend widespread pertussis vaccination for children and adults, including pregnant women.
Participants in the working group meeting will include academic researchers, industry scientists, and representatives from NVPO, CDC, the National Institutes of Health, and the Food and Drug Administration. The working group will develop a publication to make the meeting’s proceedings broadly available to the public.
Commonly called whooping cough, pertussis is a very contagious disease that affects the lungs and airways. It is caused by the bacteria Bordetella pertussis. Infants are the most vulnerable to severe complications and death.